ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Rheumatology Network

Reducing Fracture Risk

In this slideshow, we revisit some of the studies presented at the American Society for Bone and Mineral Research annual meeting recently held in Atlanta. (©ImagePointFr/Shutterstock.com)
 
 
 

Recent Content

(©Zonda/Shutterstock.com)

In this slideshow, we summarize the newly approved indications for Amgen's new biosimilar, adalimumab-atto (Amjevita) and, we highlight key points as stated by Amgen researchers.

(©PavelLPhotoVideo/Shutterstock.com)

Adalimumab for the treatment of noninfectious uveitis has advantages over no treatment or conventional treatment with steroid therapy.

©PhuShutter/Shutterstock.com

The Rheumatology Journal Club resumes its Twitter chat series this week with a focus on rheumatological immune-related adverse events in immunotherapy.

Spine (©Lightspring/Shutterstock.com)

Predictive modeling data can steer physicians toward making healthcare decisions that have positive outcomes for patients.

Elderly falls (©Toa55/Shutterstock.com)

All patients about to undergo surgery should be preoperatively evaluated for fall history, a study shows.

Bone health consult (©ImagePointFrShutterstock.com)

Bisphosphonates, bone health and more: In this slideshow, we revisit some of the studies presented at the American Society for Bone and Mineral Research annual meeting, which took place Sept. 16-19 in Atlanta.

©Lightspring/Shutterstock.com

Treating post-menopausal osteoporosis patients with romosozumab could improve their long-term bone density, a study shows.

By clicking Accept, you agree to become a member of the UBM Medica Community.